Role of AKT and PI3K Inhibitors in Patients With HR-Positive Breast Cancers: Experts Share Their Thoughts on Current Practice and Future Opportunities
Listen to this podcast with Nadia Harbeck, MD, and Francois-Clement Bidard, MD, PhD, sharing their thoughts on the role of AKT and PI3K inhibitors in patients with primary or secondary endocrine-resistant breast cancers.
You May Also Like
Thrasherway Podcast
HLT
Life Hacks DIY & More - Transform Your Everyday With Simple Tricks and DIY Magic!
Byte & Pieces
Shimon Davis
Shimon Davis
Bishop TD Jakes Sermons
Word Life
Playlist Culture G : les podcasts pour apprendre chaque jour
Acast France
Hamza Selfimprovement
Adonis Gang
Lana Blakely
Lana Blakely
Whole Again: A Fresh Approach to Mindfulness and Resilience Through Kintsugi Wisdom
Michael OBrien | Mindfulness & Resilience Coach
Hoy Hablamos: Podcast diario para aprender español - Learn Spanish Daily Podcast
Hoy Hablamos
The Happiness Habit: Building a Joyful and Fulfilling Life
Liquid Studios
Thrasherway Podcast
HLT
Life Hacks DIY & More - Transform Your Everyday With Simple Tricks and DIY Magic!
Byte & Pieces
Shimon Davis
Shimon Davis
Bishop TD Jakes Sermons
Word Life
Playlist Culture G : les podcasts pour apprendre chaque jour
Acast France
Hamza Selfimprovement
Adonis Gang
Lana Blakely
Lana Blakely
Whole Again: A Fresh Approach to Mindfulness and Resilience Through Kintsugi Wisdom
Michael OBrien | Mindfulness & Resilience Coach
Hoy Hablamos: Podcast diario para aprender español - Learn Spanish Daily Podcast
Hoy Hablamos
The Happiness Habit: Building a Joyful and Fulfilling Life
Liquid Studios
Community discussion